With dust settled on activist attack, Laurence Cooper leaves Ziopharm to a new board
Laurence Cooper has done his part.
In the five years since he left a tenured position at Houston’s MD Anderson Cancer Center to become CEO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
